2007, Number SA
<< Back Next >>
Bioquimia 2007; 32 (SA)
In vitro activity of moxifloxacin against 92 anaerobic agents isolated from human intra-abdominales in fections
Perea-Cantero RA, Rodríguez-Salazar RB, Barrera-Jiménez I
Language: Spanish
References: 7
Page: 110
PDF size: 36.07 Kb.
Text Extraction
No abstract
REFERENCES
Solomkin J.S, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003; 37: 997-1005.
Goldstein EJC, Snydman DR. Intraobdominal Infections: Antimicrobial susceptibility. J Antimicrob Chermother 2004: 53; (Suppl 2) iii29-ii36.
Ackermann G, Schaumann R, Pless B, et al. 2000. Comparative activity of moxifloxacin in-vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis 2000; 19: 228-232.
Snydman D R, Jacobus NV, Mcdermott LA, et al. 2002. In-vitro Activity of Quinolons news against Bacteroides species. Antimicrob Agentes Chemother 2002; 46: 3276-3279
Jousimies-Somer, HR, Summanen P, Citron DM, Barón E.J, Wexler HM, Finegold SM.2002. Manual In Anaerobic Bacteriology. Wadsworth-KTL. 6ª ed. Belmont: Publication by Co. Star 2002
NCCLS. Methods for dilution antimicrobial susceptibility test for bacteria that grow anaerobically. 6ª ed. Publication M11-A6 NCCLS Wayne P.A: NCCLS 2004.
Dalhoff A, Petersen U, Endermann R. In- vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 1996; 42: 410-425.
Full text